Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia

被引：0
|
作者：
L Huang
W J E Tissing
R de Jonge
B D van Zelst
R Pieters
机构：
[1] Erasmus MC-Sophia Children's Hospital,Department of Pediatric Oncology/Hematology
[2] Erasmus University Medical Center Rotterdam,Department of Pediatric Oncology/Hematology
[3] Beatrix Children's Hospital,undefined
[4] University Medical Center Groningen,undefined
[5] University of Groningen,undefined
[6] Department of Clinical Chemistry,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1798 / 1800
页数：2
相关论文
共 50 条
  • [31] GENETIC VARIATION IN FOLATE RELATED GENES AND THEIR ASSOCIATION WITH OUTCOME OF METHOTREXATE THERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    El-Neanaey, W. A.
    Hassab, H.
    El-Neily, D.
    HAEMATOLOGICA, 2014, 99 : 277 - 277
  • [32] Risk Factors of Delayed Elimination of High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia or Lymphoma
    Nakano, Takaaki
    Kobayashi, Ryouji
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Suzuki, Daisuke
    Kobayashi, Kunihiko
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S29 - S29
  • [33] Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma
    Takaaki Nakano
    Ryoji Kobayashi
    Satoru Matsushima
    Daiki Hori
    Masato Yanagi
    Daisuke Suzuki
    Kunihiko Kobayashi
    International Journal of Hematology, 2021, 113 : 744 - 750
  • [34] Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma
    Nakano, Takaaki
    Kobayashi, Ryoji
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Suzuki, Daisuke
    Kobayashi, Kunihiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (05) : 744 - 750
  • [35] INFLUENCE OF TRANSPORT PROTEIN GENE POLYMORPHISMS ON THE EFFECTS AND TOXICITY OF HIGH DOSE METHOTREXATE IN CHILDHOOD PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Lu, A.
    Zhang, L.
    Wang, B.
    Wu, J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 55 - 55
  • [36] Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
    Liu, Shu-Guang
    Gao, Chao
    Zhang, Rui-Dong
    Zhao, Xiao-Xi
    Cui, Lei
    Li, Wei-Jing
    Chen, Zhen-Ping
    Yue, Zhi-Xia
    Zhang, Yuan-Yuan
    Wu, Min-Yuan
    Wang, Jian-Xiang
    Li, Zhi-Gang
    Zheng, Hu-Yong
    ONCOTARGET, 2017, 8 (23) : 37761 - 37772
  • [37] HIGH-DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDHOOD
    MOE, PJ
    PEDIATRIC RESEARCH, 1979, 13 (08) : 951 - 951
  • [38] Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients
    Rahmayanti, Siti Utami
    Amalia, Riezki
    Rusdiana, Taofik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 141 - 155
  • [39] Pharmacokinetics of High-Dose Methotrexate in Infants Treated for Acute Lymphoblastic Leukemia
    Lonnerholm, Gudmar
    Valsecchi, Maria Grazia
    De Lorenzo, Paola
    Schrappe, Martin
    Hovi, Liisa
    Campbell, Myriam
    Mann, Georg
    Janka-Schaub, Gritta
    Li, Chi-Kong
    Stary, Jan
    Hann, Ian
    Pieters, Rob
    PEDIATRIC BLOOD & CANCER, 2009, 52 (05) : 596 - 601
  • [40] Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukemia
    Yang, L.-H. (yang_lihua@sina.com), 2005, Chinese Medical Association (40)
12345